These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. LRRK2 kinase plays a critical role in manganese-induced inflammation and apoptosis in microglia. Kim J; Pajarillo E; Rizor A; Son DS; Lee J; Aschner M; Lee E PLoS One; 2019; 14(1):e0210248. PubMed ID: 30645642 [TBL] [Abstract][Full Text] [Related]
8. LRRK2 and neuroinflammation: partners in crime in Parkinson's disease? Russo I; Bubacco L; Greggio E J Neuroinflammation; 2014 Mar; 11():52. PubMed ID: 24655756 [TBL] [Abstract][Full Text] [Related]
9. Mutations in LRRK2 impair NF-κB pathway in iPSC-derived neurons. López de Maturana R; Lang V; Zubiarrain A; Sousa A; Vázquez N; Gorostidi A; Águila J; López de Munain A; Rodríguez M; Sánchez-Pernaute R J Neuroinflammation; 2016 Nov; 13(1):295. PubMed ID: 27863501 [TBL] [Abstract][Full Text] [Related]
11. LRRK2 Inhibition Mitigates the Neuroinflammation Caused by TLR2-Specific α-Synuclein and Alleviates Neuroinflammation-Derived Dopaminergic Neuronal Loss. Ho DH; Nam D; Seo M; Park SW; Seol W; Son I Cells; 2022 Mar; 11(5):. PubMed ID: 35269482 [TBL] [Abstract][Full Text] [Related]
12. Activation of Nur77 in microglia attenuates proinflammatory mediators production and protects dopaminergic neurons from inflammation-induced cell death. Liu TY; Yang XY; Zheng LT; Wang GH; Zhen XC J Neurochem; 2017 Feb; 140(4):589-604. PubMed ID: 27889907 [TBL] [Abstract][Full Text] [Related]
13. Novel LRRK2 GTP-binding inhibitors reduced degeneration in Parkinson's disease cell and mouse models. Li T; Yang D; Zhong S; Thomas JM; Xue F; Liu J; Kong L; Voulalas P; Hassan HE; Park JS; MacKerell AD; Smith WW Hum Mol Genet; 2014 Dec; 23(23):6212-22. PubMed ID: 24993787 [TBL] [Abstract][Full Text] [Related]
14. Cysteinyl Leukotriene Receptor 2 is Involved in Inflammation and Neuronal Damage by Mediating Microglia M1/M2 Polarization through NF-κB Pathway. Zhao R; Ying M; Gu S; Yin W; Li Y; Yuan H; Fang S; Li M Neuroscience; 2019 Dec; 422():99-118. PubMed ID: 31726033 [TBL] [Abstract][Full Text] [Related]
15. The complex relationships between microglia, alpha-synuclein, and LRRK2 in Parkinson's disease. Schapansky J; Nardozzi JD; LaVoie MJ Neuroscience; 2015 Aug; 302():74-88. PubMed ID: 25284317 [TBL] [Abstract][Full Text] [Related]
16. LRRK2 kinase inhibition prevents pathological microglial phagocytosis in response to HIV-1 Tat protein. Marker DF; Puccini JM; Mockus TE; Barbieri J; Lu SM; Gelbard HA J Neuroinflammation; 2012 Nov; 9():261. PubMed ID: 23190742 [TBL] [Abstract][Full Text] [Related]
18. Phosphorylation of p53 by LRRK2 induces microglial tumor necrosis factor α-mediated neurotoxicity. Ho DH; Seol W; Eun JH; Son IH Biochem Biophys Res Commun; 2017 Jan; 482(4):1088-1094. PubMed ID: 27914807 [TBL] [Abstract][Full Text] [Related]
19. Changes in matrix metalloprotease activity and progranulin levels may contribute to the pathophysiological function of mutant leucine-rich repeat kinase 2. Caesar M; Felk S; Zach S; Brønstad G; Aasly JO; Gasser T; Gillardon F Glia; 2014 Jul; 62(7):1075-92. PubMed ID: 24652679 [TBL] [Abstract][Full Text] [Related]